Results for tag: "Flolan"

Flolan (epoprostenol) is a cardiovascular drug used to treat pulmonary arterial hypertension (PAH). It is a prostacyclin analogue that works by relaxing the blood vessels in the lungs, allowing for improved blood flow and oxygen delivery. Flolan is administered intravenously and is typically used in combination with other drugs to treat PAH. Flolan is a highly specialized drug, and the market for it is relatively small. It is primarily used in the United States, Europe, and Japan, and is prescribed by specialists in the field of pulmonary hypertension. The drug is expensive, and the cost of treatment can be a barrier to access for some patients. The Flolan market is dominated by GlaxoSmithKline, which holds the patent for the drug. Other companies in the market include Actelion Pharmaceuticals, United Therapeutics, and Pfizer. Show Less Read more